Connect with us

International

Curaleaf forced to remove products in New York for changing THC metric on label without authorization

Published

em

A Curaleaf was recently forced to remove tens of thousands of bottles of dried cannabis flower from the shelves of New York dispensaries. According to NY Cannabis Insider, the company switched to an unauthorized way of labeling potency, which led patients to believe that the cannabis they bought was much stronger than usual. This is not the first time that Curaleaf has had problems with the labels on its packaging. Last year, the company had already switched labels from THC to CBD (and vice versa) in “Select” branded products and ended up facing seven federal lawsuits in the United States, having admitted at the time to an “unintentional human error”. 

This time, the problem arose after Curaleaf started, last July, to put the “dry weight” measurements on the labels, without the authorization of the Office of Cannabis Management, the regulator of the State of New York. In New York, all products display the “wet weight” label, but the “dry weight” method shows significantly higher percentages of THC, making cannabis more attractive to buyers looking for the biggest bang for the buck.

The alert was given by a patient, Tom, who told NY Cannabis Insider that he had doubts and therefore decided to ask Curaleaf for the certificate of analysis: “I noticed that the THC on the label did not match the THC on the certificate of analysis”. After an email exchange between Tom and Curaleaf, the regulator intervened on 26 July, sending an email to Curaleaf, reiterating that the dry weight measurements “are for informational purposes only and cannot be applied labeling of approved products until an approved method is available”.

Stephanie Cunha, a spokeswoman for Curaleaf, told the NY Cannabis Insider that dry weight “is considered the most accurate metric for THC content in any type of cannabis sample.” And she added that "neighboring states like Connecticut, New Jersey and Maryland require testing based on dry weight." Cunha further explained that the company made the change to provide “a more accurate and consistent metric of THC content” to consumers, but did not respond to why the company did not seek regulatory approval. "Curaleaf holds their products to high standards and we are deeply sorry to our patient community for any confusion this change in methodology has caused."

Curaleaf said it had "temporarily removed certain products from the market, to redistribute with New York's mandatory wet weight measurement." However, the company said it was working with the regulator and believes New York State will switch to the dry weight metric soon.

Consumers seek higher percentages of THC 

At issue is the controversial issue of THC percentages. The same product can show a THC percentage of 20% if you use the wet weight metric, but it can go up to 37% when using the dry weight test. According to Geoff Brown, a pharmacist at MedMen in Buffalo and co-founder of the magazine CannaBuff, “The higher the potency of the flower, the more sales of that item we see,” he told the NY Cannabis Insider. The switch to dry weight testing resulted in a “considerable increase in sales” of Curaleaf's product at his store, Brown said, but left the dispensary staff with doubts.

Bob Miller, COO of ACT Laboratories, explained that from a laboratory perspective, dry weight allows for more accurate product-to-product or laboratory-to-lab comparisons. The downside to this approach is that it is misleading to patients… so it inflates potency.”

On the patient side, Timothy Mitchell confessed to the NY Cannabis Insider that mislabeling Curaleaf is problematic, both for accuracy and transparency: “Patients must be able to accurately assess their dose. Medicinal use is all about relieving symptoms and many of us have a clear idea of ​​what it takes to get the required result. For the sake of transparency, it is important to have accurate information, as some use medical cannabis after not getting results from the medical/pharmaceutical system and/or after feeling cheated by broken promises. Having to question whether or not our dispensaries are consciously deceiving us would be yet another setback,” he said.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 2018st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “What does Lisbon say?” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura made the documentary “Pacientes” in XNUMX and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

Interviews4 days ago

Céline Nicole de Groot: “A lot of light is needed for cannabis to express its genetic performance and maximum yield”

With a vast knowledge of physics, chemistry, thermodynamics, plant science, light and sensor technology, Céline Nicole de Groot...

International4 days ago

US: Courts increasingly restrict use of sniffer dogs in cannabis-related cases

The United States justice system is redefining the limits of police action with dogs in...

Events5 days ago

ICBC returns to Berlin on 29 and 30 April for “its biggest edition ever”

This year will be the biggest in the history of the emerging legal cannabis industry in Germany and the International...

International6 days ago

Italy: Hemp industry unites against ban on hemp flowers

A coalition of Italian business associations is launching a legal and political campaign to challenge the recent decree of the...

Interviews2 weeks ago

Maren Krings: “Hemp gave me answers to everything”

Austro-German photojournalist Maren Krings dedicated the last years of her life to documenting the many uses and applications of...

Economy2 weeks ago

Czech Republic: Analysis assesses the economic impact of legalizing cannabis in the country and sees it as an opportunity for growth and leadership

The debate over the legalization of cannabis has been gaining momentum across Europe and the Czech Republic...

Hemp2 weeks ago

Italy: Government uses “emergency” powers to ban hemp flower, criminalising 22.000 people overnight

The final nail in the coffin of Italy's booming light cannabis sector appears to have been put by the government. The...

Economy2 weeks ago

Germany keeps cannabis legalization law in political transition: what does this mean for the future?

After a decisive election victory earlier this year, the German coalition government now finds itself at the head of a...

Science2 weeks ago

Study reveals alternative to increase water solubility and gastrointestinal permeability of CBD

Cannabidiol (CBD) may offer promising therapeutic benefits for conditions such as epilepsy and neurodegenerative diseases. Despite its...

Analysis2 weeks ago

Germany: The time is now for medicinal cannabis

As projections indicate that the German medical cannabis market could exceed 200 tons of annual demand in the...